PFS

New cancer therapy research reported from National Cancer Center Hospital, Department of Medical Oncology.(Clinical report)
Blood Weekly; 11/19/2009; 1550 words; ...eligible patients achieving partial response. Median progression-fee survival (PFS) was 0.79 years (95% confidence interval: 0.52-1.40 years), and PFS at 1 and 2 years was 37 and 15%, respectively. Overall survival rates at 2 and...

New disease progression therapy research from Duke University, Department of Surgery discussed.
Cancer Weekly; 11/17/2009; 1019 words; ...SRT during a median follow-up of 50 months." "The predicted 6-year progression-free survival (PFS) was compared to the actuarial PFS using calibration plots. The accuracy of the nomogram to risk-stratify men for progression was assessed...

Study findings from University of Turin provide new insights into non-small cell lung cancer therapy.(Report)
Cancer Weekly; 11/17/2009; 1365 words; ...Secondary end points included progression-free survival (PFS), overall survival (OS), 1-year survival rate, and safety...or=8 weeks. Five patients had SD >6 months. Median PFS was 11.9 weeks (95% CI 8.6, 14.1) and median OS was...

Amgen Announces Overall Survival Results for Vectibix[R] in First-Line Metastatic Colorectal Cancer.(Financial report)
Cancer Weekly; 11/17/2009; 1129 words; ...this year, it was announced that the trial met its primary endpoint by significantly prolonging progression-free survival (PFS) in the first-line treatment of patients with KRAS wild-type mCRC (see also Colon Cancer). The prospective analysis of...

Amgen Announces Overall Survival Results for Vectibix in First-Line Metastatic Colorectal Cancer.(Financial report)
Cancer Weekly; 11/17/2009; 1251 words; ...this year, it was announced that the trial met its primary endpoint by significantly prolonging progression-free survival (PFS) in the first-line treatment of patients with KRAS wild-type mCRC (see also Amgen). The prospective analysis of the 203...